首页> 外文OA文献 >EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to Rhodiola rosea L. extract and reduction of mental fatigue pursuant to Article 13(5) of Regulation (EC) No 1924/2006
【2h】

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to Rhodiola rosea L. extract and reduction of mental fatigue pursuant to Article 13(5) of Regulation (EC) No 1924/2006

机译:EFsa饮食产品,营养和过敏专家组(NDa);关于根据第(EC)1924/2006号条例第13(5)条证实与红景天提取物和减少精神疲劳有关的健康声明的科学意见

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Following an application from Nutrilinks Sarl, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Rhodiola rosea L.extract and reduction of mental fatigue. The food constituent that is the subject of the health claim is a dry powder extract of Rhodiola rosea L., which is standardised for its content of rosavins and salidroside. The Panel considers that Rhodiola rosea L.extract is sufficiently characterised. The claimed effect is “helps to stimulate intellectual functions in situation of stress after the first intake”. Upon request by EFSA, the applicant clarified that the claimed effect related to the reduction of tiredness and fatigue in situation of stress. The target population proposed by the applicant is healthy adults in situations of fatigue and stress. The Panel considers that reduction of mental fatigue is a beneficial physiological effect. The applicant identified two published human intervention studies as pertinent to the health claim. These studies were carried out with a Rhodiola rosea L. extract which was standardised only for its salidroside content and not for its content of rosavins. The Panel notes that these studies were not undertaken with the food constituent, Rhodiola rosea L.extract, which is the subject of the health claim and which is standardised for both its rosavins and salidroside content. The Panel considers that no conclusions can be drawn from these studies for the scientific substantiation of the health claim. The Panel concludes that a cause and effect relationship has not been established between the consumption of Rhodiola rosea L.extract and reduction of mental fatigue.
机译:根据Nutrilinks Sarl的要求,根据比利时第1924/2006号法规(EC)第13条第5款通过比利时主管当局提交的申请,要求营养产品,营养和过敏问题专家组(NDA)对有关玫瑰红景天提取物和减轻精神疲劳的健康主张的科学依据。作为健康要求主题的食品成分是玫瑰红景天干粉提取物,其提取物中的罗沙芬和红景天苷含量标准化。小组认为,玫瑰红景天提取物具有足够的特征。声称的效果是“有助于在第一次摄入后在压力情况下刺激智力功能”。应欧洲食品安全局的要求,申请人澄清说,所要求的效果与减轻压力情况下的疲劳和疲劳有关。申请人提出的目标人群是处于疲劳和压力状态的健康成年人。小组认为减少精神疲劳是有益的生理作用。申请人确定了两项已发布的与健康声明有关的人为干预研究。这些研究是用玫瑰红景天提取物进行的,该提取物仅针对其红景天苷含量而不对其rosavins含量进行了标准化。小组注意到,没有对食品成分玫瑰红景天提取物进行这些研究,该成分是健康声称的主题,并且其松香和红景天苷含量均已标准化。小组认为,从这些研究中无法得出关于健康声称的科学依据的结论。专家组得出结论,食用玫瑰红景天提取物与减轻精神疲劳之间尚未建立因果关系。

著录项

  • 作者

    Tetens Inge;

  • 作者单位
  • 年度 2012
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号